About us

Neuropeutics is a pharmaceutical company developing targeted therapies to extend neurodegenerative disease patients’ survival and improve their quality of life.

Provide the first effective treatment for TDP-43-centered neurodegenerative diseases.

Discover and develop innovative treatments to alleviate neurodegenerative diseases. 

Neuropeutics' team of experts is dedicated to advancing the discovery and development of novel treatments for neurodegenerative diseases. We leverage 150+ years of collective expertise in neurodegenerative diseases research, diagnosis, clinical trials and business development to revolutionize the treatment of these debilitating conditions.